Literature DB >> 17082654

Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node.

Gabriele Hintzen1, Lars Ohl, Maria-Luisa del Rio, Jose-Ignacio Rodriguez-Barbosa, Oliver Pabst, Jessica R Kocks, Janet Krege, Svenja Hardtke, Reinhold Förster.   

Abstract

Allergic airway diseases such as asthma are caused by a failure of the immune system to induce tolerance against environmental Ags. The underlying molecular and cellular mechanisms that initiate tolerance are only partly understood. In this study, we demonstrated that a CCR7-dependent migration of both CD103+ and CD103- lung dendritic cells (DC) to the bronchial lymph node (brLN) is indispensable for this process. Although inhaled Ag is amply present in the brLN of CCR7-deficient mice, T cells cannot be tolerized because of the impaired migration of Ag-carrying DC and subsequent transport of Ag from the lung to the draining lymph node. Consequently, the repeated inhalation of Ag protects wild-type but not CCR7-deficient mice from developing allergic airway diseases. Thus, the continuous DC-mediated transport of inhaled Ag to the brLN is critical for the induction of tolerance to innocuous Ags.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082654     DOI: 10.4049/jimmunol.177.10.7346

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis.

Authors:  Simona Schlereth; Hyun Soo Lee; Payal Khandelwal; Daniel R Saban
Journal:  Am J Pathol       Date:  2012-04-14       Impact factor: 4.307

Review 2.  Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.

Authors:  Benjamin D Clarkson; Erika Héninger; Melissa G Harris; JangEun Lee; Matyas Sandor; Zsuzsanna Fabry
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 3.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 4.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  Pulmonary CD103(+) dendritic cells prime Th2 responses to inhaled allergens.

Authors:  H Nakano; M E Free; G S Whitehead; S Maruoka; R H Wilson; K Nakano; D N Cook
Journal:  Mucosal Immunol       Date:  2011-10-19       Impact factor: 7.313

6.  Spatiotemporal and functional behavior of airway dendritic cells visualized by two-photon microscopy.

Authors:  Tibor Z Veres; Tibor Zoltán Veres; Sabrina Voedisch; Emma Spies; Thomas Tschernig; Armin Braun
Journal:  Am J Pathol       Date:  2011-06-25       Impact factor: 4.307

7.  Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration.

Authors:  Asolina Braun; Tim Worbs; G Leandros Moschovakis; Stephan Halle; Katharina Hoffmann; Jasmin Bölter; Anika Münk; Reinhold Förster
Journal:  Nat Immunol       Date:  2011-08-14       Impact factor: 25.606

8.  Ectopic activation of Mycobacterium tuberculosis-specific CD4+ T cells in lungs of CCR7-/- mice.

Authors:  Sofia Olmos; Sabriya Stukes; Joel D Ernst
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

9.  Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage.

Authors:  Susan N Thomas; Joseph M Rutkowski; Miriella Pasquier; Emma L Kuan; Kari Alitalo; Gwendalyn J Randolph; Melody A Swartz
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

10.  Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus.

Authors:  JiChu Li; JooHung Park; Deborah Foss; Irving Goldschneider
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.